Commonwealth of Pennsylvania Public School Empls Retrmt SYS Lowers Stock Position in Progyny, Inc. (NASDAQ:PGNY)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS trimmed its position in shares of Progyny, Inc. (NASDAQ:PGNY) by 5.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,816 shares of the company’s stock after selling 972 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Progyny were worth $273,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the company. Signaturefd LLC increased its stake in Progyny by 1,355.0% during the fourth quarter. Signaturefd LLC now owns 1,455 shares of the company’s stock worth $25,000 after acquiring an additional 1,355 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Progyny by 341.4% in the 4th quarter. GAMMA Investing LLC now owns 1,611 shares of the company’s stock valued at $28,000 after purchasing an additional 1,246 shares in the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Progyny by 108.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company’s stock worth $51,000 after purchasing an additional 1,526 shares during the period. Caitlin John LLC increased its position in Progyny by 2,974.8% during the 4th quarter. Caitlin John LLC now owns 3,290 shares of the company’s stock worth $57,000 after purchasing an additional 3,183 shares in the last quarter. Finally, SBI Securities Co. Ltd. purchased a new position in Progyny in the fourth quarter valued at approximately $74,000. 94.93% of the stock is owned by hedge funds and other institutional investors.

Progyny Price Performance

Shares of Progyny stock opened at $22.31 on Friday. Progyny, Inc. has a 1-year low of $13.39 and a 1-year high of $38.98. The company has a market capitalization of $1.91 billion, a PE ratio of 38.47, a P/E/G ratio of 2.39 and a beta of 1.41. The business has a 50-day moving average of $22.05 and a 200-day moving average of $18.58.

Analyst Upgrades and Downgrades

PGNY has been the subject of several research reports. Canaccord Genuity Group boosted their price objective on shares of Progyny from $17.00 to $23.00 and gave the stock a “hold” rating in a research note on Friday, February 28th. Bank of America upped their price target on shares of Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a research report on Tuesday, February 11th. Finally, JPMorgan Chase & Co. raised their price objective on Progyny from $17.00 to $23.00 and gave the company a “neutral” rating in a research report on Tuesday, January 28th. Nine research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $24.82.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.